We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

74 hedge funds and large institutions have $868M invested in Vaxcyte in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 39 increasing their positions, 13 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

36,000% more call options, than puts

Call options by funds: $361K | Put options by funds: $1K

200% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 13

2.82% more ownership

Funds ownership: 82.95% → 85.76% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

11% less funds holding

Funds holding: 83 → 74 (-9)

22% less capital invested

Capital invested by funds: $1.12B → $868M (-$251M)

50% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 18

Holders
74
Holders Change
-9
Holders Change %
-10.84%
% of All Funds
1.3%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
9
Increased
39
Reduced
13
Closed
18
Calls
$361K
Puts
$1K
Net Calls
+$360K
Net Calls Change
+$360K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$33.3M
2
State Street
State Street
Massachusetts
+$21.4M
3
BlackRock
BlackRock
New York
+$12.5M
4
SCM
Soleus Capital Management
Connecticut
+$7.39M
5
IC
Ikarian Capital
Texas
+$5.66M

Top Sellers

Rank Fund Capital Flow
1
PBPIA
Pivotal bioVenture Partners Investment Advisor
California
-$20.6M
2
FCMI
Foresite Capital Management IV
California
-$12.4M
3
Franklin Resources
Franklin Resources
California
-$10.6M
4
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$9.63M
5
LGM
Logos Global Management
California
-$3.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
LGM
76
Logos Global Management
California
– -$3.72M -140,000 Closed
PPA
77
Parametric Portfolio Associates
Washington
– -$948K -35,663 Closed
PL
78
Parkwood LLC
Ohio
– -$749K -28,191 Closed
Russell Investments Group
79
Russell Investments Group
United Kingdom
– -$590K -22,229 Closed
Norges Bank
80
Norges Bank
Norway
– -$531K -20,000 Closed
Marshall Wace
81
Marshall Wace
United Kingdom
– -$383K -14,426 Closed
Squarepoint
82
Squarepoint
New York
– -$298K -11,233 Closed
AC
83
Athanor Capital
New York
– -$284K -10,675 Closed
CPIG
84
Chicago Partners Investment Group
Illinois
– -$268K -10,653 Closed
JG
85
Jefferies Group
New York
– -$266K -10,000 Closed
CSS
86
Cubist Systematic Strategies
Connecticut
– -$260K -9,768 Closed
HLA
87
Hamilton Lane Advisors
Pennsylvania
– -$242K -9,091 Closed
EGM
88
Engineers Gate Manager
New York
– -$235K -8,840 Closed
JF
89
Jump Financial
Illinois
– -$215K -8,100 Closed
OQS
90
Occudo Quantitative Strategies
Florida
– -$215K -8,089 Closed
SFI
91
Susquehanna Fundamental Investments
Pennsylvania
– -$205K -7,732 Closed
MPWT
92
MassMutual Private Wealth & Trust
Connecticut
– +$403 +16 New
1 2 3
4

PCVX Hedge Fund Activity: Q1 2021 in Review

74 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q1 2021, worth a combined $868M — down 22% from $1.12B a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of PCVX and 9 opened new positions — a net loss of 9 holders — while 13 trimmed existing stakes and 39 added.

The largest buyer was Vanguard Group, adding an estimated $33.3M. The largest seller was Pivotal bioVenture Partners Investment Advisor, cutting an estimated $20.6M.

  • 74 institutional investors held Vaxcyte (PCVX) as of Q1 2021, down from 83 in Q4 2020.
  • Funds reported $868M of Vaxcyte stock for Q1 2021, down 22% quarter-over-quarter.
  • 9 funds opened new Vaxcyte positions in Q1 2021 and 18 closed out, a net change of -9 holders.
  • The largest Vaxcyte buyer in Q1 2021 was Vanguard Group, an estimated $33.3M added.
  • The largest Vaxcyte seller in Q1 2021 was Pivotal bioVenture Partners Investment Advisor, an estimated $20.6M sold.

Based on aggregated 13F filings for Q1 2021.